KPWS
MRNA icon

Kestra Private Wealth Services’s Moderna MRNA Stock Holding History

Kestra Private Wealth Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,306
Closed -$288K – 1470
2024
Q3 		$288K Sell
4,306
-36
-0.8% -$3.31K 0.01% 1097
2024
Q2 		$516K Sell
4,342
-756
-15% -$95.7K 0.01% 818
2024
Q1 		$543K Buy
5,098
+8
+0.2% +$806 0.01% 765
2023
Q4 		$506K Sell
5,090
-177
-3% -$14.9K 0.01% 723
2023
Q3 		$544K Buy
5,267
+527
+11% +$58.8K 0.02% 634
2023
Q2 		$576K Buy
4,740
+300
+7% +$40K 0.02% 591
2023
Q1 		$682K Sell
4,440
-67
-1% -$11.1K 0.03% 509
2022
Q4 		$810K Sell
4,507
-130
-3% -$21.3K 0.04% 411
2022
Q3 		$548K Buy
4,637
+12
+0.3% +$1.82K 0.03% 467
2022
Q2 		$661K Sell
4,625
-1,624
-26% -$232K 0.04% 426
2022
Q1 		$1.08M Sell
6,249
-675
-10% -$114K 0.05% 359
2021
Q4 		$1.76M Buy
6,924
+491
+8% +$144K 0.08% 251
2021
Q3 		$2.48M Buy
6,433
+1,763
+38% +$650K 0.14% 167
2021
Q2 		$1.1M Sell
4,670
-510
-10% -$91.1K 0.07% 311
2021
Q1 		$678K Sell
5,180
-616
-11% -$89.3K 0.05% 388
2020
Q4 		$644K Buy
5,796
+61
+1% +$6.17K 0.05% 382
2020
Q3 		$406K Buy
+5,735
New +$400K 0.04% 425

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Kestra Private Wealth Services's MRNA Position: Q4 2024 in Review

Kestra Private Wealth Services sold out of Moderna (MRNA) in Q4 2024, closing a stake of 4,306 shares — an estimated $288K sold.

Kestra Private Wealth Services first reported a position in MRNA in Q3 2020 and held it in 17 quarters. The position peaked at $2.48M in Q3 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Kestra Private Wealth Services reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Kestra Private Wealth Services sold 4,306 Moderna shares in Q4 2024, an estimated $288K.
  • Kestra Private Wealth Services first reported a position in Moderna in Q3 2020 and held it in 17 quarters.
  • Kestra Private Wealth Services's Moderna position peaked at $2.48M in Q3 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Kestra Private Wealth Services's 13F filing for Q4 2024, filed 28 Jan 2025.